Werner Enterprises [WERN] vs Rxo [RXO] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Werner Enterprises Inc. wins in 11 metrics, Rxo Inc. wins in 8 metrics, with 0 ties. Werner Enterprises Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Werner Enterprises Inc. | Rxo Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 84.78 | 645.33 | Werner Enterprises Inc. |
| Price-to-Book Ratio | 1.49 | 2.04 | Werner Enterprises Inc. |
| Debt-to-Equity Ratio | 57.08 | 43.48 | Rxo Inc. |
| PEG Ratio | -0.25 | 5.16 | Rxo Inc. |
| EV/EBITDA | 7.97 | 34.81 | Werner Enterprises Inc. |
| Profit Margin (TTM) | -0.48% | -1.74% | Werner Enterprises Inc. |
| Operating Margin (TTM) | 2.86% | -0.61% | Werner Enterprises Inc. |
| EBITDA Margin (TTM) | 2.86% | N/A | N/A |
| Return on Equity | -1.59% | -6.34% | Werner Enterprises Inc. |
| Return on Assets (TTM) | 1.33% | -0.13% | Werner Enterprises Inc. |
| Free Cash Flow (TTM) | $-68.53M | $-8.00M | Rxo Inc. |
| Dividend Yield | 2.04% | N/A | N/A |
| 1-Year Return | 59.28% | 84.69% | Rxo Inc. |
| Price-to-Sales Ratio (TTM) | 0.68 | 0.55 | Rxo Inc. |
| Enterprise Value | $2.79B | $3.79B | Rxo Inc. |
| EV/Revenue Ratio | 0.94 | 0.66 | Rxo Inc. |
| Gross Profit Margin (TTM) | 10.83% | 13.00% | Rxo Inc. |
| Revenue per Share (TTM) | $49 | $34 | Werner Enterprises Inc. |
| Earnings per Share (Diluted) | $-0.24 | $-0.59 | Werner Enterprises Inc. |
| Beta (Stock Volatility) | 1.10 | 1.53 | Werner Enterprises Inc. |
| Short % of Float | 6.40% | 24.27% | Werner Enterprises Inc. |
Werner Enterprises Inc. vs Rxo Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Werner Enterprises Inc. | -2.02% | -3.24% | 15.44% | 58.00% | 40.38% | 40.71% |
| Rxo Inc. | -2.26% | -1.28% | 48.26% | 131.69% | 84.73% | 115.81% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Werner Enterprises Inc. | 59.28% | -0.83% | 3.05% | 80.53% | 80.91% | 124.63% |
| Rxo Inc. | 84.69% | 26.85% | 31.86% | 31.86% | 31.86% | 31.86% |
Performance & Financial Health Analysis: Werner Enterprises Inc. vs Rxo Inc.
| Metric | WERN | RXO |
|---|---|---|
| Market Information | ||
| Market Cap | $2.03B | $3.18B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 903,627 | 1,942,255 |
| 90 Day Avg. Volume | 964,992 | 1,877,215 |
| Last Close | $43.07 | $27.71 |
| 52 Week Range | $23.06 - $45.27 | $10.43 - $29.86 |
| % from 52W High | -4.86% | -7.20% |
| All-Time High | $50.31 (Jan 30, 2023) | $32.82 (Jul 29, 2024) |
| % from All-Time High | -14.39% | -15.57% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | -0.12% |
| Quarterly Earnings Growth | -0.02% | -0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | -0.02% |
| Operating Margin (TTM) | 0.03% | -0.01% |
| Return on Equity (TTM) | -0.02% | -0.06% |
| Debt to Equity (MRQ) | 57.08 | 43.48 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $22.76 | $9.39 |
| Cash per Share (MRQ) | $1.00 | $0.10 |
| Operating Cash Flow (TTM) | $181.83M | $51.00M |
| Levered Free Cash Flow (TTM) | $-10,835,625 | $42.75M |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.04% | N/A |
| Last 12-Month Dividend | $0.70 | N/A |
Valuation & Enterprise Metrics Analysis: Werner Enterprises Inc. vs Rxo Inc.
| Metric | WERN (Apr 26, 2026) | RXO (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 84.78 | 645.33 |
| Forward P/E | 18.82 | 49.16 |
| PEG Ratio | -0.25 | 5.16 |
| Price to Sales (TTM) | 0.68 | 0.55 |
| Price to Book (MRQ) | 1.49 | 2.04 |
| Market Capitalization | ||
| Market Capitalization | $2.03B | $3.18B |
| Enterprise Value | $2.79B | $3.79B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.94 | 0.66 |
| Enterprise to EBITDA | 7.97 | 34.81 |
| Risk & Other Metrics | ||
| Beta | 1.10 | 1.53 |
| Book Value per Share (MRQ) | $22.76 | $9.39 |
Financial Statements Comparison: Werner Enterprises Inc. vs Rxo Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | WERN (2025) | RXO (2025) |
|---|---|---|
| Revenue/Sales | 2.97B | 5.74B |
| Cost of Goods Sold | 2.69B | 4.92B |
| COGS % of Revenue | 90.3% | 85.6% |
| Gross Profit | 288.41M | 825.00M |
| Gross Margin | 9.7% | 14.4% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 55.88M | -7.00M |
| Operating Margin | 1.9% | -0.1% |
| EBITDA | 348.88M | 108.00M |
| EBITDA Margin | 11.7% | 1.9% |
| Pre-Tax Income | -20.79M | -115.00M |
| Pre-Tax Income % of Revenue | -0.7% | -2.0% |
| Income Tax | 2.21M | -15.00M |
| Income Tax % of Revenue | 0.1% | -0.3% |
| Net Income (Profit) | -23.00M | -100.00M |
| Profit Margin | -0.8% | -1.7% |
Balance Sheet & Liquidity Metrics
| Metric | WERN (2025) | RXO (2025) |
|---|---|---|
| Cash & Equivalents | 59.92M | 17.00M |
| Total Current Assets | 612.85M | 1.32B |
| Total Current Assets % of Revenue | 20.6% | 22.9% |
| Total Current Liabilities | 314.78M | 1.04B |
| Total Current Liabilities % of Revenue | 10.6% | 18.1% |
| Long-Term Debt | 752.00M | 578.00M |
| Long-Term Debt % of Revenue | 25.3% | 10.1% |
| Total Shareholders Equity | 1.39B | 1.54B |
| Retained Earnings | 1.90B | -384.00M |
| Retained Earnings % of Revenue | 64.0% | -6.7% |
| Property, Plant & Equipment | 2.41B | 238.00M |
Cash Flow Statement Comparison
| Metric | WERN (2025) | RXO (2025) |
|---|---|---|
| Operating Cash Flow | 198.09M | 33.00M |
| Operating Cash Flow % of Revenue | 6.7% | 0.6% |
| Capital Expenditures | -162.75M | -57.00M |
| Free Cash Flow | -68.53M | -8.00M |
| FCF Margin | -2.3% | -0.1% |
| Debt Repayment | -378.00M | -535.00M |
| Common Stock Repurchase | -55.55M | 0 |
Short Interest & Institutional Ownership Analysis
| Metric | WERN | RXO |
|---|---|---|
| Shares Short | 2.81M | 13.95M |
| Short Ratio | 2.73 | 7.29 |
| Short % of Float | 6.40% | 24.27% |
| Shares Outstanding | 59.87M | 164.16M |
| Float Shares | 58.70M | 125.56M |
| % Held by Insiders | 1.24% | 0.86% |
| % Held by Institutions | 107.28% | 107.88% |
| % Held by Public | -8.52% | -8.74% |
Dividend Analysis & Yield Comparison: Werner Enterprises Inc. vs Rxo Inc.
| Metric | WERN | RXO |
|---|---|---|
| Last 12-Month Dividend | $0.70 | N/A |
| Last 12-Month Dividend Yield | 2.04% | N/A |
| 3-Year Avg Annual Dividend | $0.60 | N/A |
| 3-Year Avg Dividend Yield | 0.40% | N/A |
| 3-Year Total Dividends | $1.81 | N/A |
| Ex-Dividend Date | Apr 13, 2026 | N/A |